Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
基本信息
- 批准号:7163698
- 负责人:
- 金额:$ 33.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2009-07-14
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntibiotic ResistanceAntibioticsAttentionBacteriaBiochemicalBiological AssayBioterrorismClassClostridium perfringensClostridium perfringens epsilon toxinComplementCultured CellsDNADevelopmentDiseaseEnteralEnterotoxinsEventFacility Construction Funding CategoryForensic MedicineGene TransferGenerationsGenesGenomeGoalsHandIn VitroInfectionInjection of therapeutic agentInsertional MutagenesisIntestinesIntravenousInvestigationKnock-outMedicalModelingMolecularParentsPartner in relationshipPathogenesisPlasmidsProcessPulsed-Field Gel ElectrophoresisRangeResearchSeriesStudy SectionSystemic diseaseTechniquesTestingToxic effectToxinVariantVirulencebiodefenseimprovedin vitro Assayin vivointravenous injectionmutantpathogenpromoterresearch studytherapeutic vaccinetooltransmission process
项目摘要
Clostridium perfringens type B, C, and D isolates have significant medical, veterinary, and biodefense
importance. Several toxins (e.g. select agent "B" list epsilon toxin and beta toxin) expressed by type B-D
isolates are encoded by genes present on large plasmids. The long-term goal of this project is to fully
understand how those little-studied plasmids contribute to the virulence of type B-D isolates. To start
progressing towards this goal, the following specific aims will be pursued: i) contructing isogenic single and
double toxin knock-out mutants in type B-D backgrounds using insertional mutagenesis approaches, 2)
comparing the virulence of these newly-constructed isogenic mutants against their parents (and
complemented mutants strains); this will be accomplished using in vivo and in vitro approaches that will
evaluate enteric virulence (intestinal loop models), systemic virulence (intravenous injections of culture
supernatants} and effects of an intraduodenal challenge mimicking the entire disease spectrum (i.e., both
enteric and systemic disease), 3) using Aim #1 toxin mutants, which will carry virulence plasmids tagged with
antibiotic resistance determinants, in mixed mating experiments to evaluate whether type B-D virulence
plasmids can transfer between C. perfringens isolates via conjugation, 4) conducting phenotypic/genotypic
analyses to evaluate the diversity of these isolates; these studies will involve examining type B-D isolates to
determine how much beta- and/or epsilon-toxin (as appropriate) they produce, testing whether those toxin
expression differences are related to promoter differences, determining if some type B-D isolates produce
beta- or epsilon-toxin variants (as appropriate) with altered biologic activities, and examining the diversity of
type B-D plasmid genomes using pulsed-field gel electrophoresis and microarray approaches, and 5)
investigating non-toxin virulence plasmid functions by insertional inactivation approaches; if Aim #3 confirms
that type B-D virulence plasmids can transfer via conjugation, Aim #5 will initially target putative DNA
transfer genes on these plasmids. These studies are expected to provide critical information for developing
improved vaccines/therapeutics against type B-D infections and for developing molecular assays to subtype
these isolates, as necessary for forensic investigations in the event that type B-D isolates are deliberately
released during a bioterrorism event.
B,C和D分离株类型梭状芽胞杆菌具有明显的医学,兽医和生物底面
重要性。 B-D类型表达的几种毒素(例如选择代理“ B”列表Epsilon毒素和β毒素)
分离株由存在于大质粒上的基因编码。该项目的长期目标是完全
了解那些小研究的质粒如何有助于B-D型分离株的毒力。开始
朝着这一目标迈进,将追求以下特定目标:i)造成的等源性单一和
B-D型背景中使用插入诱变方法中的双重毒素敲除突变体,2)
比较这些新结构的同基因突变体与父母的毒力(以及
补充突变体菌株);这将使用体内和体外方法来完成
评估肠道毒力(肠环模型),全身毒力(静脉注射培养物
上清液}以及模仿整个疾病频谱的二次挑战的影响(即
3)使用AIM#1毒素突变体,该突变体将带有标记的毒力质粒
在混合交配实验中,抗生素耐药性决定因素,以评估B-D型毒力是否是否
质粒可以通过共轭之间转移C.浓度分离菌分离株,4)传导表型/基因型
分析以评估这些分离株的多样性;这些研究将涉及检查B-D型分离株至
确定它们产生多少β-和/或Epsilon toxin(根据适当),测试这些毒素是否存在
表达差异与启动子差异有关,确定某种B-D分离株是否产生
随着生物学活性改变的β-或Epsilon toxin变体(适当),并检查的多样性
B-D质质粒基因组使用脉冲场凝胶电泳和微阵列方法,5)
通过插入失活方法研究非毒素毒力质粒功能;如果AIM#3确认
该类型的B-D毒力质粒可以通过共轭转移,AIM#5最初将靶向推定的DNA
在这些质粒上转移基因。期望这些研究为开发提供关键信息
改善了针对B-D型感染的疫苗/治疗剂,并用于将分子测定到亚型开发分子测定
这些分离株,对于B-D型分离株故意的法医调查的必要条件
在生物恐怖事件中发行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce A Mc Clane其他文献
Bruce A Mc Clane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce A Mc Clane', 18)}}的其他基金
NanI sialidase: Effects on Clostridium perfringens enterotoxin activity and contributions to C. perfringens type F infection
NanI 唾液酸酶:对产气荚膜梭菌肠毒素活性的影响以及对产气荚膜梭菌 F 型感染的贡献
- 批准号:
10055797 - 财政年份:2020
- 资助金额:
$ 33.7万 - 项目类别:
NanI sialidase: Effects on Clostridium perfringens enterotoxin activity and contributions to C. perfringens type F infection
NanI 唾液酸酶:对产气荚膜梭菌肠毒素活性的影响以及对产气荚膜梭菌 F 型感染的贡献
- 批准号:
10183154 - 财政年份:2020
- 资助金额:
$ 33.7万 - 项目类别:
Early interaction between clostridium perfringens epsilon toxin and host cells
产气荚膜梭菌ε毒素与宿主细胞之间的早期相互作用
- 批准号:
8233380 - 财政年份:2011
- 资助金额:
$ 33.7万 - 项目类别:
Early interaction between clostridium perfringens epsilon toxin and host cells
产气荚膜梭菌ε毒素与宿主细胞之间的早期相互作用
- 批准号:
7670079 - 财政年份:2009
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
7884390 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
6838204 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
8503578 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
6676995 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
8288751 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
Clostridium perfringens Type B-D Virulence Plasmids
产气荚膜梭菌 B-D 型毒力质粒
- 批准号:
6765902 - 财政年份:2003
- 资助金额:
$ 33.7万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights
探究人类抗葡萄球菌抗体反应以获得金黄色葡萄球菌疫苗见解
- 批准号:
10826874 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别:
Metabolic determinants of Staphylococcus aureus skin colonization
金黄色葡萄球菌皮肤定植的代谢决定因素
- 批准号:
10749745 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别:
Development of a model of Gonococcal conjunctivitis for vaccine evaluations
开发用于疫苗评估的淋菌性结膜炎模型
- 批准号:
10740430 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别:
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
- 批准号:
10693593 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别: